HROW fundamentals
Harrow, Inc. revenue breakdown overview
Harrow, Inc. revenue for the last year amounted to 198.80 M USD, the most of which — 130.19 M USD — came from its highest performing source at the moment, Innovative Ophthalmic Therapies, the year earlier bringing 88.59 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Harrow, Inc. 130.19 M USD, and the year before that — 88.59 M USD.
By source
2016
2017
2018
2019
2020
2021
2022
2023
0.00
35.00 M
70.00 M
105.00 M
140.00 M
Innovative Ophthalmic Therapies
Pharmaceutical Compounding
Sales
License
Currency: USD
2016
2017
2018
2019
2020
2021
2022
2023
Innovative Ophthalmic Therapies
—
—
—
88.59 M
130.19 M
Pharmaceutical Compounding
51.16 M
48.87 M
72.48 M
—
—
Sales
—
—
—
—
—
License
—
—
—
—
—
By country
2016
2017
2018
2019
2020
2021
2022
2023
0.00
35.00 M
70.00 M
105.00 M
140.00 M
United States
Currency: USD
2016
2017
2018
2019
2020
2021
2022
2023
United States
51.16 M
48.87 M
72.48 M
88.59 M
130.19 M